Clinical trial NCT03485898: Study of Patients Hospitalized in Specialized Cognitive-behavioral Unit (UCC)
Official title: Patient Outcomes After an Hospitalization in the Specialized Cognitive-behavioral Unit (UCC) of Toulon
Study type: OBSERVATIONAL
Overall status: TERMINATED
Conditions: Behavior Disorders
Keywords: UCC
mortality
alzheimer's disease
longitudinal study
Lead sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Sponsor class: OTHER
First posted: 2018-04-03
Enrollment: 58
Sex: ALL
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: The population correspond to all inpatient from the UCC of Toulon

Brief summary: The purpose of the study is to assess the mortality of patient discharged from the specialized cognitive-behavioral unit (UCC) of Toulon.

Detailed description: The purpose of specialized cognitive-behavioral unit is to take care of patients demented, valid and with disruptive behavior disorders. The hypothesis is that analyzing the healthcare of these discharged patients might provide a view of the benefices of these units.

The study will be explained to the eligible subjects if they are able to understand it, or to their trusted person, primary caregiver or legal representative.

Medical information will be collected during and after the hospitalization in the specialized cognitive-behavioral unit. The investigator will call the medical staff and the primary caregiver at 3, 6, and 12 months after the patient's discharge, in order to collect study data.

Eligibility criteria: Inclusion Criteria:

* Inpatient at the UCC of Toulon

Exclusion Criteria:

* Patient already included in the study ( a patient cannot be included twice during the study)
* Non-affiliated to a social security regimen
* Objection of the patient, the trusted person, the legal representative, the relative or the member of the family (depending on the overall condition of the patient)

Primary outcomes:
measure: Mortality rate at 12 month after patient's discharge from UCC
timeFrame: 12 months
Secondary outcomes:
measure: Mortality rate at 3 and 6 month after patient's discharge from UCC
timeFrame: 3 and 6 months
measure: Assess the primary mortality risk factors regarding all the collected data.
timeFrame: 12 months
measure: Create a predictive score for 6 and 12 month mortality
timeFrame: 6 and 12 months
measure: Mortality rate during the hospitalization in the UCC
timeFrame: 12 months
measure: Analysis of hospitalisation rate
timeFrame: 12 months
measure: Analysis of the number of treatment taken during the study
timeFrame: 12 months
measure: Analysis of the different classes of treatment taken during the study
timeFrame: 12 months
measure: Analysis of the treatment's mode of delivery
timeFrame: 12 months
Other outcomes:
Locations:
city: Toulon
country: France
facility: Centre Hospitalier Intercommunal de Toulon La-Seyne-sur-Mer
Study officials:
affiliation: Centre Hospitalier Intercommunal Toulon La Seyne sur Mer
name: Romain Van overloop, doctor
role: PRINCIPAL_INVESTIGATOR
References:
citation: Walsh JS, Welch HG, Larson EB. Survival of outpatients with Alzheimer-type dementia. Ann Intern Med. 1990 Sep 15;113(6):429-34. doi: 10.7326/0003-4819-113-6-429.
citation: Molsa PK, Marttila RJ, Rinne UK. Survival and cause of death in Alzheimer's disease and multi-infarct dementia. Acta Neurol Scand. 1986 Aug;74(2):103-7. doi: 10.1111/j.1600-0404.1986.tb04634.x.
citation: Edland SD, Rocca WA, Petersen RC, Cha RH, Kokmen E. Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn. Arch Neurol. 2002 Oct;59(10):1589-93. doi: 10.1001/archneur.59.10.1589.
citation: Fitzpatrick AL, Kuller LH, Lopez OL, Kawas CH, Jagust W. Survival following dementia onset: Alzheimer's disease and vascular dementia. J Neurol Sci. 2005 Mar 15;229-230:43-9. doi: 10.1016/j.jns.2004.11.022. Epub 2004 Dec 23.
citation: Lee M, Chodosh J. Dementia and life expectancy: what do we know? J Am Med Dir Assoc. 2009 Sep;10(7):466-71. doi: 10.1016/j.jamda.2009.03.014. Epub 2009 Jun 27.
citation: Mitchell SL, Kiely DK, Hamel MB, Park PS, Morris JN, Fries BE. Estimating prognosis for nursing home residents with advanced dementia. JAMA. 2004 Jun 9;291(22):2734-40. doi: 10.1001/jama.291.22.2734.
citation: Mitchell SL, Miller SC, Teno JM, Davis RB, Shaffer ML. The advanced dementia prognostic tool: a risk score to estimate survival in nursing home residents with advanced dementia. J Pain Symptom Manage. 2010 Nov;40(5):639-51. doi: 10.1016/j.jpainsymman.2010.02.014.
citation: Mitchell SL, Miller SC, Teno JM, Kiely DK, Davis RB, Shaffer ML. Prediction of 6-month survival of nursing home residents with advanced dementia using ADEPT vs hospice eligibility guidelines. JAMA. 2010 Nov 3;304(17):1929-35. doi: 10.1001/jama.2010.1572.